rs61748814
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_025074.7(FRAS1):c.11717T>C(p.Ile3906Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0178 in 1,613,872 control chromosomes in the GnomAD database, including 302 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. I3906I) has been classified as Likely benign.
Frequency
Consequence
NM_025074.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRAS1 | NM_025074.7 | c.11717T>C | p.Ile3906Thr | missense_variant | 74/74 | ENST00000512123.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.11717T>C | p.Ile3906Thr | missense_variant | 74/74 | 5 | NM_025074.7 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0138 AC: 2101AN: 152200Hom.: 18 Cov.: 32
GnomAD3 exomes AF: 0.0135 AC: 3366AN: 249138Hom.: 32 AF XY: 0.0140 AC XY: 1896AN XY: 135170
GnomAD4 exome AF: 0.0183 AC: 26707AN: 1461554Hom.: 284 Cov.: 31 AF XY: 0.0180 AC XY: 13097AN XY: 727038
GnomAD4 genome ? AF: 0.0138 AC: 2100AN: 152318Hom.: 18 Cov.: 32 AF XY: 0.0135 AC XY: 1007AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Fraser syndrome 1 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 15, 2024 | BA1, BS2, BP4 - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at